ArcelorMittal S.A.: ArcelorMittal announces the publication of its first quarter 2024 sell-side analyst consensus figures
April 25, 2024 08:27 ET
|
ArcelorMittal S.A.
25 April 2024, 14:30 CET ArcelorMittal (‘the Company’) today announces the publication of its first quarter 2024 sell-side analyst consensus figures. The consensus figures are based on...
Form 8.3 - Irish Residential Properties REIT plc
April 25, 2024 08:23 ET
|
State Street International (Ireland) Limited
FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH...
ACNB Corporation Reports 2024 First Quarter Financial Results
April 25, 2024 08:22 ET
|
ACNB Corporation
GETTYSBURG, Pa., April 25, 2024 (GLOBE NEWSWIRE) -- ACNB Corporation (NASDAQ: ACNB) (“ACNB” or the “Corporation”), financial holding company for ACNB Bank and ACNB Insurance Services, Inc.,...
Shop LC Secures Renewed Lease In Round Rock, Still Committed To Land In Cedar Park
April 25, 2024 08:17 ET
|
Shop LC
Austin, TX, April 25, 2024 (GLOBE NEWSWIRE) -- Shop LC, a prominent local employer and community contributor, announces the renewal of its leases in Round Rock, TX, for an additional five years....
Imperial Reports Production Update for 2024 First Quarter
April 25, 2024 08:15 ET
|
Imperial Metals Corporation
VANCOUVER, British Columbia, April 25, 2024 (GLOBE NEWSWIRE) -- Imperial Metals Corporation (“Imperial”) (TSX:III) reports quarterly copper and gold production from Mount Polley and Red Chris mines....
Aztec Group appoints new Head of U.S. Markets
April 25, 2024 08:15 ET
|
Aztec Group
Aztec Group, a leading fund and corporate services provider, appoints Scott Kraemer as Head of U.S. Markets to lead its offering across North America.
Theriva™ Biologics to Discuss the Trial Design for VIRAGE - a Phase 2b Clinical Study of Systemically Administered VCN-01 in Combination with Chemotherapy in Pancreatic Ductal Adenocarcinoma - at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
April 25, 2024 08:15 ET
|
Theriva Biologics, Inc.
ROCKVILLE, Md., April 25, 2024 (GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related...
Kimo Inc. Transitions to Public Company and Begins Trading on OTCQB Under Ticker Symbol KIMO
April 25, 2024 08:15 ET
|
Kimo Inc
~ Listing Marks Significant Milestone as the Company Enters Next Phase of its Growth ~ ~ Public Transition Provides Greater Visibility and Convenience for U.S. Retail and Institutional Investors ~ ...
maXTouch® Touchscreen Controller Family Expands with Additional Security Features for Touchscreen Payment Systems
April 25, 2024 08:09 ET
|
Microchip Technology Inc.
Microchip’s MXT2952TD 2.0 family of secure touchscreen controllers is designed to help protect payment architectures on outdoor terminals.
Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals
April 25, 2024 08:05 ET
|
Shareholder Capital LLC
Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals